Tag: WTO trade disputes

On April 2, 2025, President Donald Trump announced a sweeping overhaul of U.S. trade policy, introducing a baseline 10% tariff on all imports and significantly higher rates for certain countries, notably China. This move, termed "Liberation Day" by the administration, aimed to address longstanding trade imbalances and protect domestic industries. The immediate aftermath saw global markets plunge, with the S&P 500 experiencing its worst single-day decline since the 2020 pandemic-induced crash . However, a subsequent 90-day tariff pause, announced on April 9, led to a market rebound, highlighting the volatility and uncertainty surrounding the administration's trade strategies.

In April 2025, the U.S. inflation rate decreased to 2.3%, marking the lowest level since February 2021 . This development occurs against the backdrop of President Donald Trump's recent tariff adjustments, including the introduction of new levies and subsequent partial rollbacks. The interplay between these tariff policies and inflation dynamics presents a complex scenario with significant legal, economic, and policy considerations.

In early 2025, President Donald Trump reasserted his "America First" trade agenda, initiating a series of aggressive tariff measures aimed at addressing longstanding trade deficits and promoting domestic manufacturing. These policies, characterized by substantial tariffs on imports from key trading partners, have led to significant market volatility and raised complex legal questions regarding the extent of executive power in trade matters.

On May 4, 2025, President Donald Trump announced a proposal to impose a 100% tariff on foreign films. This declaration, made via his social media platform, has sent shockwaves through the global film industry, raising concerns about its legality, economic impact, and cultural ramifications. “This is a direct attack on the global nature of the film industry and could have far-reaching consequences,” said Dr. Emily Carter, Professor of International Trade Law at Columbia University. The proposed tariff aims to penalize U.S. studios that outsource film production to countries offering tax incentives, such as the United Kingdom, Canada, and Australia. Trump justified the move by citing national security concerns and the need to revitalize domestic film production. However, critics argue that such a tariff could violate international trade agreements and disrupt the collaborative nature of modern filmmaking.

In April 2025, President Donald Trump announced plans to impose pharmaceutical tariffs, signaling a significant shift in U.S. trade and healthcare policy. This move aims to repatriate critical industry supply chains to the United States, leveraging national security concerns to justify trade measures without congressional approval. The proposed tariffs are expected to particularly affect pharmaceutical exporters from countries like Britain and Ireland, which collectively enjoy a substantial trade surplus with the U.S..

In April 2025, former President Donald J. Trump, having returned to the White House, unveiled a sweeping new round of tariffs targeting China and other major trade partners, including the European Union, Canada, and Mexico. The most severe measures include tariffs of up to 145% on Chinese imports and steep increases on goods ranging from automobiles to electronics from allied nations. Though pitched as a bold assertion of economic sovereignty, this new tariff regime has already begun reshaping global markets, sparking retaliatory threats, and provoking urgent legal and political scrutiny.